Ronald Blue Trust, Inc. Grifols Sa Transaction History
Ronald Blue Trust, Inc.
- $8.31 Billion
- Q2 2025
A detailed history of Ronald Blue Trust, Inc. transactions in Grifols Sa stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 6,568 shares of GRFS stock, worth $65,482. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,568
Previous 8,886
26.09%
Holding current value
$65,482
Previous $63,000
6.35%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding GRFS
# of Institutions
170Shares Held
153MCall Options Held
42.9KPut Options Held
82.4K-
Brandes Investment Partners, LP La Jolla, CA28MShares$280 Million2.4% of portfolio
-
Capital World Investors Los Angeles, CA21.7MShares$216 Million0.03% of portfolio
-
Permian Investment Partners, LP New York, NY18.6MShares$186 Million32.54% of portfolio
-
Black Creek Investment Management Inc. Toronto, A612.6MShares$125 Million5.56% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny9.67MShares$96.4 Million0.05% of portfolio
About Grifols SA
- Ticker GRFS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 678,910,976
- Market Cap $6.77B
- Description
- Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...